References
- de Lanerolle NC, Kim JH, Robbins RJ, et al. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 1989; 495(2):387–395.
- Krumholz A, Sung GY, Fisher RS, et al. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. 1995; 45(8):1499–1504.
- Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia. 1999;40(1):120–122.
- Engrand N, Crespel A. Bases physiopathologiques des états de mal épileptiques. Rev Neurol. 2009;165 (4):315–319. 2009.
- Musto AE, Rosencrans RF, Walker CP, et al. Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism. Sci Rep. 2016;6:30298.
- Dhote F, Carpentier P, Barbier L, et al. Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice. Toxicol Appl Pharmacol. 2012;1259(2):195–209.
- Santi SA, Cook LL, Persinger MA, et al. Normal spatial memory following postseizure treatment with ketamine: selective damage attenuates memory deficits in brain-damaged rodents. Int J Neurosci. 2001; Mar107(1-2):63–75.
- Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007;2(2):322–328.
- Can A, Dao DT, Arad M, et al. The Mouse Forced Swim Test. J Vis Exp. 2012;59:e3638.
- Deacon R. Measuring motor coordination in mice. J Vis Exp. 2013;75:e2609.
- de Oliveira DL, Fischer A, Jorge RS, et al. Effects of early-life LiCl-Pilocarpine-induced status epilepticus on memory and anxiety in adult rats are associated with mossy fiber sprouting and elevated CSF S100B protein. Epilepsia. 2008;49(5):842–852.
- Rice AC, Delorenzo RJ. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res. 1998;;782(1/2):240–247.
- Gröticke I, Hoffmann K, Löscher W. Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate. Exp Neurol. 2008;213(1):71–83.
- Gröticke I, Hoffmann K, Löscher W. Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice. Exp Neurol. 2007;207(2):329–349.
- Loss CM, Córdova SD, De Oliveira DL. Ketamine reduces neuronal degeneration and anxiety levels when administered during early life-induced status epilepticus in rats. Brain Res. 2007;207(2):329–349.
- Mcgirr A, Ledue J, Chan AW, et al. Cortical functional hyperconnectivity in a mouse model of depression and selective network effects of ketamine. Brain. 2017;140(8):2210–2225.
- da Silva FCC, do Carmo de Oliveira Cito M, da Silva MIG, et al. Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice. Brain Res Bull. 2010;83(1-2):9–15.
- Pham TH, Mendez-David I, Defaix C, et al. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice. Neuropharmacology. 2017;112(Pt A):198–209.
- Browne CA, Lucki I. Antidepressant effects of ketamine: Mechanisms underlying fast-acting novel antidepressants. Front Pharmacol. 2013;4:1–18.
- Duman RS. Pathophysiology of depression and innovative treatments: Remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci. 2014;16(1):11–27.
- Umpierre AD, Remigio GJ, Dahle EJ, et al. Impaired cognitive ability and anxiety-like behavior following acute seizures in the Theiler’s virus model of temporal lobe epilepsy. Neurobiol Dis. 2014;64:98–106.
- Curia G, Longo D, Biagini G, et al. The pilocarpine model of temporal lobe epilepsy. J. Neurosci Methods. 2008;172(2):143–157.
- Russo I, Bonini D, Via LL, et al. AMPA receptor properties are modulated in the early stages following pilocarpine-induced status epilepticus. Neuromol Med. 2013;15(2):324–338.
- Bower MR, Buckmaster PS. Changes in granule cell firing rates precede locally recorded spontaneous seizures by minutes in an animal model of temporal lobe epilepsy. J Neurophysiol. 2008;99(5):2431–2442.
- Dey A, Kang X, Qiu J, et al. Anti-inflammatory small molecules to treat seizures and epilepsy: from bench to bedside. Trends Pharmacol Sci. 2016;37(6):463–484.